Detail akcie Ekso Bionics Rg online

Business Summary: Ekso Bionics Holdings, Inc. designs, develops, and markets exoskeleton products. Its exoskeleton technology serves people with physical disabilities or impairments in both physical rehabilitation and mobility. It operates as one segment with two markets: Enterprise Health and Personal Health. Its products include EksoNR, which is a wearable robotic exoskeleton designed for a rehabilitation setting; Ekso Indego Therapy is a modular, adjustable, lightweight, lower limb-powered exoskeleton; Ekso Indego Personal is a lower limb orthosis; Ekso Nomad is a power Knee Ankle Foot Orthosis, and Ekso EVO is a wearable upper body exoskeleton. It enables individuals with neurological conditions affecting gait, including acquired brain injury (ABI) and spinal cord injury (SCI), to rehabilitate, stand and walk again. Additionally, the devices assist people with a variety of upper extremity disabilities and enable industrial employees to perform challenging repetitive tasks for extended periods.
Financial Summary: BRIEF: For the nine months ended 30 September 2025, Ekso Bionics Holdings Inc revenues decreased 25% to $9.7M. Net loss applicable to common stockholders decreased 8% to $7.2M. Revenues reflect United States segment decrease of 12% to $6M, France segment decrease of 41% to $1.2M. Lower net loss reflects Unrealized gain on foreign exchange increase from $194K to $2M (income), Sales and marketing - Balancing value decrease of 13% to $4.7M (expense).